SCHEMBL29358153

SCHEMBL29358153

COC1(OC)C(=O)c2c(O)cc(O)cc2O[C@]1(OC)c1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
CBS P35520 1/20 0.40
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 3/20 0.37
POLB P06746 2/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
BLM P54132 1/20 0.37
TYR P14679 1/20 0.36
CYP19A1 P11511 4/20 0.35
CYP3A4 P08684 3/20 0.35
CYP1A1 P04798 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP1B1 Q16678 2/20 0.35
ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29356872 0.72 CBS (0.44) ALDH1A1CBSMMP2MMP3MMP9
SCHEMBL3937086 0.72 MAOA (0.41) ALDH1A1CBSMMP2MMP3MMP9
SCHEMBL29360007 0.72 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL27586967 0.69 ALDH1A1 (0.41) ALDH1A1CBSMMP2MMP3MMP9
SCHEMBL11641427 0.69 ALDH1A1 (0.41) ALDH1A1CBSMMP2MMP3MMP9
SCHEMBL29366564 0.69 CBS (0.41) ALDH1A1CBSMMP2MMP3MMP9
SCHEMBL912011 0.68 ALDH1A1 (0.40) ALDH1A1MMP2MMP3MMP9MMP13
SCHEMBL30696627 0.67 CYP19A1 (0.43) ALDH1A1CBSMMP2MMP3MMP9
SCHEMBL30696551 0.67 CYP19A1 (0.43) ALDH1A1CBSMMP2MMP3MMP9
SCHEMBL30792837 0.67 CBS (0.43) ALDH1A1CBSMMP2MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504731-A Naringenin derivative containing 1,3, 4-oxadiazole acylhydrazone structure and preparation method thereof 广东省科学院测试分析研究所(中国广州分析测试中心) 2025-02-25 CN disclosed
US-11814563-B2 Bioreachable chiral dopants for liquid crystal applications ZYMERGEN INC. (US) 2023-11-14 US disclosed
US-20220025267-A1 BIOREACHABLE CHIRAL DOPANTS FOR LIQUID CRYSTAL APPLICATIONS ZYMERGEN ACQUISITION SUB, INC. 2022-01-27 US disclosed